Tapewire

Nasdaq · USD

ALDX

Aldeyra Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6839
SEC CIK
0001341235
Parsed reports
168

Last 12 months

Inside the activity.

3 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 30, 2022 Filed Apr 1, 2022 23:37 UTC
Machatha StephenChief Development Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0000899243-22-013173 · doc4.xml · derivative · entry 3

Machatha Stephen · CIK 0001836354 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-03-29

F4 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.

Read SEC document
March 30, 2022 Filed Apr 1, 2022 23:37 UTC
Machatha StephenChief Development Officer
GrantCommon Stock 64,395 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-013173 · doc4.xml · nonDerivative · entry 1

Machatha Stephen · CIK 0001836354 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,658

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · balance_after: Includes 2,972 shares previously purchased under the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 408 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023013 · doc4.xml · derivative · entry 3

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408

Underlying: Common Stock · 408 shares

Expires 2031-06-07

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 3,500 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023013 · doc4.xml · derivative · entry 2

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 3,500 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023013 · doc4.xml · derivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 17:45 UTC GrantStock Option (Right to Buy) · Derivative 1,750 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023010 · doc4.xml · derivative · entry 3

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2031-06-07

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 17:45 UTC GrantStock Option (Right to Buy) · Derivative 408 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023010 · doc4.xml · derivative · entry 2

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408

Underlying: Common Stock · 408 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 17:45 UTC GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023010 · doc4.xml · derivative · entry 1

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 875 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023012 · doc4.xml · derivative · entry 3

Phillips Gary M. · CIK 0001197795 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires 2031-06-07

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 1,167 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023012 · doc4.xml · derivative · entry 2

Phillips Gary M. · CIK 0001197795 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,167

Underlying: Common Stock · 1,167 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023012 · doc4.xml · derivative · entry 1

Phillips Gary M. · CIK 0001197795 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 583 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023011 · doc4.xml · derivative · entry 2

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 583

Underlying: Common Stock · 583 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:46 UTC GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023011 · doc4.xml · derivative · entry 1

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:45 UTC
Walker NealDirector
GrantStock Option (Right to Buy) · Derivative 583 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023009 · doc4.xml · derivative · entry 2

Walker Neal · CIK 0001604457 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 583

Underlying: Common Stock · 583 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:45 UTC
Walker NealDirector
GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023009 · doc4.xml · derivative · entry 1

Walker Neal · CIK 0001604457 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:44 UTC GrantStock Option (Right to Buy) · Derivative 933 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023007 · doc4.xml · derivative · entry 3

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 933

Underlying: Common Stock · 933 shares

Expires 2031-06-07

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:44 UTC GrantStock Option (Right to Buy) · Derivative 875 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023007 · doc4.xml · derivative · entry 2

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires 2031-06-07

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:44 UTC GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0000899243-21-023007 · doc4.xml · derivative · entry 1

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:55 UTC PurchaseCommon Stock 1,200,000 $12.50 $15,000,000.00
Disclosure

SEC source: 0001062993-21-004109 · form4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 9,903,879

F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
May 03, 2021 Filed Oct 22, 2024 00:22 UTC PurchaseCommon Stock 413 $12.81 $5,290.53
Disclosure

SEC source: 0000950170-24-116048 · ownership.xml · nonDerivative · entry 1

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413

F1 · kind: The purchases reported herein were executed under the trading discretion of an investment advisor in a managed account, without any instruction from or knowledge of the Reporting Person. The Reporting Person only recently become aware of these transactions.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 23:25 UTC
Reed JoshuaChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 150,185 $0.00 Strike: $11.71 $0.00
Disclosure

SEC source: 0000899243-21-015839 · doc4.xml · derivative · entry 1

Reed Joshua · CIK 0001746541 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,185

Underlying: Common Stock · 150,185 shares

Expires 2031-04-11

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2021.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 23:24 UTC
Machatha StephenChief Development Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 116,201 $0.00 Strike: $11.71 $0.00
Disclosure

SEC source: 0000899243-21-015838 · doc4.xml · derivative · entry 1

Machatha Stephen · CIK 0001836354 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,201

Underlying: Common Stock · 116,201 shares

Expires 2031-04-11

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2021.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 23:23 UTC
Brady Todd CDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $11.71 $0.00
Disclosure

SEC source: 0000899243-21-015837 · doc4.xml · derivative · entry 2

Brady Todd C · CIK 0001579179 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2031-04-11

F2 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2021.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 23:23 UTC
Brady Todd CDirector · President and CEO
GrantCommon Stock 46,619 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-015837 · doc4.xml · nonDerivative · entry 1

Brady Todd C · CIK 0001579179 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 948,835

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 22:24 UTC PurchaseCommon Stock 1,368,421 $9.50 $12,999,999.50
Disclosure

SEC source: 0001062993-21-000506 · form4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 8,703,879

F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 02:53 UTC PurchaseCommon Stock 50,000 $7.60 $380,000.00
Disclosure

SEC source: 0001062993-21-000275 · form4.xml · nonDerivative · entry 4

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 7,335,458

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 02:53 UTC PurchaseCommon Stock 152,668 $10.21 $1,558,740.28
Disclosure

SEC source: 0001062993-21-000275 · form4.xml · nonDerivative · entry 3

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 7,285,458

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.63 to $10.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 02:53 UTC PurchaseCommon Stock 347,332 $9.21 $3,198,927.72
Disclosure

SEC source: 0001062993-21-000275 · form4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 7,132,790

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.63 to $9.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
January 07, 2021 Filed Jan 12, 2021 02:53 UTC PurchaseCommon Stock 500,000 $8.13 $4,065,000.00
Disclosure

SEC source: 0001062993-21-000275 · form4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,785,458

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $8.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 20:30 UTC PurchaseCommon Stock 3,200,000 $4.25 $13,600,000.00
Disclosure

SEC source: 0000899243-20-019004 · doc4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,285,458

F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 16:49 UTC
TREU JESSE IDirector
GrantStock Option (right to buy) · Derivative 2,311 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000904454-20-000398 · edgar.xml · derivative · entry 3

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,311

Underlying: Common Stock · 2,311 shares

Expires 2030-06-08

F3 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 16:49 UTC
TREU JESSE IDirector
GrantStock Option (right to buy) · Derivative 2,465 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000904454-20-000398 · edgar.xml · derivative · entry 2

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,465

Underlying: Common Stock · 2,465 shares

Expires 2030-06-08

F2 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 16:49 UTC
TREU JESSE IDirector
GrantStock Option (right to buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000904454-20-000398 · edgar.xml · derivative · entry 1

TREU JESSE I · CIK 0001013425 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:48 UTC GrantStock Option (Right to Buy) · Derivative 1,079 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016182 · doc4.xml · derivative · entry 3

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,079

Underlying: Common Stock · 1,079 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:48 UTC GrantStock Option (Right to Buy) · Derivative 9,245 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016182 · doc4.xml · derivative · entry 2

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,245

Underlying: Common Stock · 9,245 shares

Expires 2030-06-08

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:48 UTC GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016182 · doc4.xml · derivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 17:47 UTC GrantStock Option (Right to Buy) · Derivative 4,623 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016181 · doc4.xml · derivative · entry 3

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,623

Underlying: Common Stock · 4,623 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 17:47 UTC GrantStock Option (Right to Buy) · Derivative 1,079 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016181 · doc4.xml · derivative · entry 2

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,079

Underlying: Common Stock · 1,079 shares

Expires 2030-06-08

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 17:47 UTC GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016181 · doc4.xml · derivative · entry 1

JOYCE MARTIN JOSEPH · CIK 0001300858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:45 UTC GrantStock Option (Right to Buy) · Derivative 3,082 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016177 · doc4.xml · derivative · entry 2

Phillips Gary M. · CIK 0001197795 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,082

Underlying: Common Stock · 3,082 shares

Expires 2030-06-08

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:45 UTC GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016177 · doc4.xml · derivative · entry 1

Phillips Gary M. · CIK 0001197795 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:51 UTC GrantStock Option (Right to Buy) · Derivative 1,541 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016185 · doc4.xml · derivative · entry 3

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,541

Underlying: Common Stock · 1,541 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:51 UTC GrantStock Option (Right to Buy) · Derivative 2,311 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016185 · doc4.xml · derivative · entry 2

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,311

Underlying: Common Stock · 2,311 shares

Expires 2030-06-08

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:51 UTC GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016185 · doc4.xml · derivative · entry 1

Bronstein Ben · CIK 0001604458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:48 UTC GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016183 · doc4.xml · derivative · entry 1

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:46 UTC
Walker NealDirector
GrantStock Option (Right to Buy) · Derivative 1,541 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016180 · doc4.xml · derivative · entry 2

Walker Neal · CIK 0001604457 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,541

Underlying: Common Stock · 1,541 shares

Expires 2030-06-08

F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
June 09, 2020 Filed Jun 11, 2020 21:46 UTC
Walker NealDirector
GrantStock Option (Right to Buy) · Derivative 26,503 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-20-016180 · doc4.xml · derivative · entry 1

Walker Neal · CIK 0001604457 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503

Underlying: Common Stock · 26,503 shares

Expires 2030-06-08

F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.

Read SEC document
March 16, 2020 Filed Mar 17, 2020 20:38 UTC PurchaseCommon Stock 40,000 $2.75 $110,000.00
Disclosure

SEC source: 0000899243-20-008616 · doc4.xml · nonDerivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Read SEC document
March 02, 2020 Filed Mar 5, 2020 00:49 UTC
Reed JoshuaChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 137,707 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0000899243-20-007067 · doc4.xml · derivative · entry 2

Reed Joshua · CIK 0001746541 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,707

Underlying: Common Stock · 137,707 shares

Expires 2030-03-01

F2 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020.

Read SEC document
March 02, 2020 Filed Mar 5, 2020 00:49 UTC
Reed JoshuaChief Financial Officer
GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-007067 · doc4.xml · nonDerivative · entry 1

Reed Joshua · CIK 0001746541 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,774

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.